Pharmaceutical Gelatin Market by Source (Porcine, Bovine Skin, Bovine Bone, Fish, Poultry), Application (Hard Capsule, Soft Capsule, Tablet, Absorbable Hemostat), Function (Stabilizing, Thickening, Gelling), Region - Global Forecasts to 2027
Market Growth Outlook Summary
The global pharmaceutical gelatin market growth forecasted to transform from $1.1 billion in 2022 to $1.5 billion by 2027, driven by a CAGR of 5.5%. Growth of this market is attributable to various factors such as rising demand for pharma gelatin in vaccines, tablets, and other applications. Furthermore, the launch of the novel, technologically advanced, and user-friendly pharma gelatin is likely to increase global demand.
To know about the assumptions considered for the study, Request for Free Sample Report
Pharmaceutical Gelatin Market Dynamics
Drivers: Advantages and properties of gelatin
The unique functional capabilities of gelatin, such as gelling, adhesion, coating, binding, and film-building make it highly advantageous for use in the pharmaceutical industry. Gelatin coating on hard capsules, softgel capsules, and tablets not only masks the odor of medicines but also enables easy ingestion. Moreover, gelatin's properties shield against environmental changes associated with the atmosphere, thereby increasing the shelf-life of these products. These superior functional properties of gelatin are increasing the adoption of gelatin in the pharma industry hence propelling the market growth.
Restraints: Shifts towards non-gelatin capsules
In recent years, there has been a rising trend in veganism across the world, which is defined as the abstinence from animal-based products. These trends have also extended to the pharmaceutical industry, with capsule manufacturers offering non-gelatin capsules or vegetarian capsules manufactured from purely plant-derived materials to meet the demands of consumers. The increasing demand for plant-based pharmaceutical products and subsequent changes in their product portfolios by capsule manufacturers is anticipated to hamper the growth of pharma gelatin market
Opportunities : Demand of pharma gelatin in developing countries
Emerging economies such as the Asia Pacific, the Middle East, Latin America, and Africa provide significant opportunities for the growth of the market. Global raw gelatin and gelatin capsule manufacturers have been capitalizing on this demand by expanding their business presence and production capacities in these regions. The increasing demand in emerging economies, coupled with lower raw material and labor costs, offer lucrative growth opportunities for the growth of the market during the forecast period.
Hard Capsules dominated the application segment.
Based on application, the pharmaceutical gelatin market is segmented into hard capsules, softgel capsules, tablets, absorbable hemostats & other applications. The softgel capsules segment is expected to witness the highest growth in the pharmaceutical gelatin market during the forecast period. The softgel capsules are beneficial for low-dose lipid-soluble drugs as they permit more content uniformity between dosage units are likely to increase the demand, subsequently impacting the growth of the segment.
Porcine held the highest share in the pharmaceutical gelatin market
Porcine source held a dominant share of the market. The market is segmented into porcine, bovine skin, bovine, bone, marine, and poultry. The short manufacturing cycle and economical production with the porcine are some of the major factors driving the segment's growth. Marine segment is expected to gain a substantial share during the forecast period owing to an increased focus on the launch of fish gelatin in market.
Stabilizing agent dominated function segment.
Based on function, the market is segmented into stabilizing agents, thickening agents and gelling agents & other functions. Stabilizing agents held a dominant share in the function segment. Stabilizing agent held dominant share in pharmaceutical gelatin market. Increasing use of gelatin as stabilizer in vaccines is likely to upsurge the segmental growth. Furthermore, gelatin also protects vaccine viruses from freeze-drying or heat, during delivery and transport.
Type B gelatin held highest market share in the pharmaceutical gelatin market
Based on type, the market is segmented into type A and type B gelatin. Type B segment held largest share in pharmaceutical gelatin market. The dominance is attributable to various factors such as low production cost owing to easy availability of raw material and its use in various applications across pharmaceutical industry.
North America accounted for largest share in pharmaceutical gelatin market
The global pharmaceutical gelatin market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America reported for the largest share of the pharmaceutical gelatin market followed by Europe and Asia Pacific respectively. Asia Pacific is anticipated to grow at faster pace owing to various factors such as availability of raw materials and the presence of capsule manufactures in the region. Furthermore, geographical expansion by key market players in the Asia Pacific region is likely to increase the demand subsequently projecting the market growth during the forecast period.
To know about the assumptions considered for the study, download the pdf brochure
Key players in the pharmaceutical gelatin market includes Darling Ingredients Inc. (US), Nitta Gelatin Inc (Japan), Tessenderlo Group (Belgium), Gelita AG (Germany), Weishardt (France), among others.
Pharmaceutical Gelatin Market Report Scope
|
Report Metric |
Details |
|
Market Revenue in 2022 |
$1.1 billion |
|
Estimated Value by 2027 |
$1.5 billion |
|
Growth Rate |
poised to grow at a CAGR of 5.5% |
|
Largest Share Segments |
Porcine Segment & Type B Gelatin |
|
Market Report Segmentation |
Application, Source, Function, Type & Region |
|
Growth Drivers |
|
|
Growth Opportunities |
|
|
Geographies covered |
North America, Europe, APAC, MEA, and Latin America |
This report categorizes the pharmaceutical gelatin market into the following segments
By Application
- Hard capsules
- Softgel capsules
- Tablets
- Absorbable Hemostats
- Other applications
By Source
- Porcine
- Bovine skin
- Bovine bone
- Marine
- Poultry
By Function
- Stabilizing agent
- Thickening agent
- Gelling agent & other function
By Type
- Type A
- Type B
By Region
-
North America
- US
- Canada
-
Europe
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe
-
Asia Pacific
- China
- Japan
- India
- Rest of Asia Pacific
- Latin America
- Middle East & Africa
Recent Developments
- In May 2021, Darling Ingredients Inc. announced that its Rousselot brand expanded its range of purified pharmaceutical-grade modified gelatin with the launch of X-Pure GelDAT – Gelatin Desaminotyrosine for biomedical applications.
- In July 2022, Gelita opened a biotech hub for developing proteins from biotechnological processes for applications in nutrition, cosmetics, and pharmaceutical and medical products.
Frequently Asked Questions (FAQs):
What is the size of Pharmaceutical Gelatin Market?
The global pharmaceutical gelatin market size is projected to reach USD 1.5 billion by 2027, growing at a CAGR of 5.5%.
Why is Pharmaceutical Gelatin Market Growing?
Growth of this market is attributable to various factors such as rising demand for pharma gelatin in vaccines, tablets, and other applications. Furthermore, the launch of the novel, technologically advanced, and user-friendly pharma gelatin is likely to increase global demand.
Who all are the prominent players of Pharmaceutical Gelatin Market?
Key players in the pharmaceutical gelatin market includes Darling Ingredients Inc. (US), Nitta Gelatin Inc (Japan), Tessenderlo Group (Belgium), Gelita AG (Germany), Weishardt (France), among others.
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.
TABLE OF CONTENTS
1 INTRODUCTION (Page No. - 28)
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 YEARS CONSIDERED
1.3.2 CURRENCY CONSIDERED
1.4 LIMITATIONS
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY (Page No. - 32)
2.1 RESEARCH DATA
FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.2 PRIMARY DATA
FIGURE 2 PHARMACEUTICAL GELATIN MARKET: BREAKDOWN OF PRIMARIES
2.2 MARKET ESTIMATION METHODOLOGY
2.2.1 REVENUE MAPPING-BASED MARKET ESTIMATION
FIGURE 3 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2021)
FIGURE 4 AVERAGE MARKET SIZE ESTIMATION (2021)
2.3 DATA TRIANGULATION APPROACH
FIGURE 5 DATA TRIANGULATION METHODOLOGY
2.4 GROWTH RATE ASSUMPTIONS
2.5 RISK ASSESSMENT
2.6 GROWTH FORECAST
2.6.1 SUPPLY-SIDE ANALYSIS
2.6.1.1 Insights from primary experts
3 EXECUTIVE SUMMARY (Page No. - 41)
FIGURE 6 PHARMACEUTICAL GELATIN MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION)
FIGURE 7 PHARMACEUTICAL GELATIN MARKET, BY SOURCE, 2022 VS. 2027 (USD MILLION)
FIGURE 8 PHARMACEUTICAL GELATIN MARKET SHARE, BY FUNCTION, 2021
FIGURE 9 PHARMACEUTICAL GELATIN MARKET SHARE, BY TYPE, 2021
FIGURE 10 GEOGRAPHICAL SNAPSHOT OF PHARMACEUTICAL GELATIN MARKET
4 PREMIUM INSIGHTS (Page No. - 45)
4.1 PHARMACEUTICAL GELATIN MARKET OVERVIEW
FIGURE 11 VERSATILITY OF GELATIN IN PHARMACEUTICAL AND BIOMEDICAL APPLICATIONS TO DRIVE MARKET GROWTH
4.2 ASIA PACIFIC: PHARMACEUTICAL GELATIN MARKET SHARE, BY APPLICATION (2021)
FIGURE 12 HARD CAPSULES ACCOUNTED FOR LARGEST SHARE IN 2021
4.3 PHARMACEUTICAL GELATIN MARKET SHARE, BY SOURCE, 2022 VS. 2027
FIGURE 13 PORCINE GELATIN TO DOMINATE MARKET DURING FORECAST PERIOD
4.4 PHARMACEUTICAL GELATIN MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 14 CHINA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
5 MARKET OVERVIEW (Page No. - 48)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 15 PHARMACEUTICAL GELATIN MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Advantages and properties of gelatin
5.2.1.2 Launch of advanced pharma gelatins
5.2.1.3 Increasing biomedical applications of gelatin
5.2.2 RESTRAINTS
5.2.2.1 Cultural restrictions in certain regions
5.2.2.2 Shift toward non-gelatin capsules
5.2.3 OPPORTUNITIES
5.2.3.1 Demand for pharma gelatin in developing countries
5.2.3.2 Adoption of gelatin in vaccines and biomedical applications
5.2.4 CHALLENGES
5.2.4.1 Insufficient raw materials
5.2.4.2 Increasing incidence of animal-borne diseases
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
FIGURE 16 REVENUE SHIFTS AND NEW REVENUE POCKETS FOR PHARMACEUTICAL GELATIN
5.4 PRICING ANALYSIS
5.4.1 AVERAGE SELLING PRICE TREND
TABLE 1 AVERAGE SELLING PRICE OF PHARMACEUTICAL GELATIN, BY REGION
5.4.2 INDICATIVE PRICING ANALYSIS, BY MARKET PLAYER
TABLE 2 XIAMEN GELKEN GELATIN: AVERAGE SELLING PRICE OF PHARMACEUTICAL GELATIN
TABLE 3 HENAN BOOM GELATIN: AVERAGE SELLING PRICE OF PHARMACEUTICAL GELATIN
5.5 VALUE CHAIN ANALYSIS
FIGURE 17 PHARMACEUTICAL GELATIN MARKET: VALUE CHAIN ANALYSIS
5.5.1 SOURCING OF RAW MATERIAL
5.5.2 COLLECTION AND TRANSPORT OF RAW MATERIAL
5.5.3 RAW MATERIAL PREPARATION AND PROCESSING
5.5.4 GELATIN PRODUCTION
5.6 ECOSYSTEM ANALYSIS
5.6.1 FARMING INPUT
5.6.2 FARMING
5.6.3 SLAUGHTERING
5.6.4 MANUFACTURING
5.6.5 SUPPLIERS/DISTRIBUTORS
5.6.6 END-PRODUCT MANUFACTURERS
FIGURE 18 PHARMACEUTICAL GELATIN MARKET: ECOSYSTEM ANALYSIS
5.6.7 ROLE IN ECOSYSTEM
5.7 TECHNOLOGY ANALYSIS
TABLE 4 PHARMACEUTICAL GELATIN MARKET: TECHNOLOGICAL ADVANCEMENTS, 2019–2022
5.8 PATENT ANALYSIS
5.8.1 LIST OF MAJOR PATENTS
5.9 PORTER’S FIVE FORCES ANALYSIS
TABLE 5 PHARMACEUTICAL GELATIN MARKET: PORTER’S FIVE FORCES ANALYSIS
5.9.1 COMPETITIVE RIVALRY AMONG EXISTING PLAYERS
5.9.2 BARGAINING POWER OF SUPPLIERS
5.9.3 BARGAINING POWER OF BUYERS
5.9.4 THREAT FROM SUBSTITUTES
5.9.5 THREAT FROM NEW ENTRANTS
5.10 KEY STAKEHOLDERS AND BUYING CRITERIA
FIGURE 19 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR PHARMACEUTICAL GELATIN
FIGURE 20 KEY BUYING CRITERIA FOR PHARMACEUTICAL GELATIN AMONG END USERS
5.11 REGULATORY LANDSCAPE
5.11.1 NORTH AMERICA
5.11.2 EUROPE
5.11.3 ASIA PACIFIC
5.11.4 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 6 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.12 TRADE ANALYSIS
5.12.1 US
5.12.2 INDIA
TABLE 7 TOP IMPORTERS OF GELATIN FROM INDIA, BY VALUE, 2020-2021 (APR-NOV)
5.12.3 BRAZIL
5.12.4 OVERVIEW OF GELATIN TRADE/IMPEX, BY COUNTRY
5.13 KEY CONFERENCES & EVENTS IN 2022–2023
TABLE 8 PHARMACEUTICAL GELATIN MARKET: DETAILED LIST OF EVENTS AND CONFERENCES
6 PHARMACEUTICAL GELATIN MARKET, BY APPLICATION (Page No. - 67)
6.1 INTRODUCTION
TABLE 9 PHARMACEUTICAL GELATIN MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
6.2 HARD CAPSULES
6.2.1 ADVANTAGES OF GELATIN-BASED HARD CAPSULES TO PROPEL MARKET
TABLE 10 TYPICAL HARD GELATIN CAPSULE COMPOSITION
TABLE 11 DIMENSIONS (IN MILLIMETERS) AND VOLUME (IN MILLIMETERS) OF TWO-PIECE HARD CAPSULES
TABLE 12 PHARMACEUTICAL GELATIN MARKET FOR HARD CAPSULES, BY REGION, 2020–2027 (USD MILLION)
TABLE 13 NORTH AMERICA: PHARMACEUTICAL GELATIN MARKET FOR HARD CAPSULES, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 14 EUROPE: PHARMACEUTICAL GELATIN MARKET FOR HARD CAPSULES, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 15 ASIA PACIFIC: PHARMACEUTICAL GELATIN MARKET FOR HARD CAPSULES, BY COUNTRY, 2020–2027 (USD MILLION)
6.3 SOFTGEL CAPSULES
6.3.1 RISING DEMAND FOR SOFTGEL CAPSULES IN PHARMA INDUSTRY TO DRIVE GROWTH
TABLE 16 DIFFERENCES BETWEEN HARD CAPSULES AND SOFTGEL CAPSULES
TABLE 17 PHARMACEUTICAL GELATIN MARKET FOR SOFTGEL CAPSULES, BY REGION, 2020–2027 (USD MILLION)
TABLE 18 NORTH AMERICA: PHARMACEUTICAL GELATIN MARKET FOR SOFTGEL CAPSULES, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 19 EUROPE: PHARMACEUTICAL GELATIN MARKET FOR SOFTGEL CAPSULES, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 20 ASIA PACIFIC: PHARMACEUTICAL GELATIN MARKET FOR SOFTGEL CAPSULES, BY COUNTRY, 2020–2027 (USD MILLION)
6.4 TABLETS
6.4.1 USE OF GELATIN AS BINDERS IN TABLETS TO CONTRIBUTE TO SEGMENTAL GROWTH
TABLE 21 IN VITRO PROPERTIES OF TABLETS WITH GELATIN AS BINDER (CONCENTRATIONS 2.0-8.0%)
TABLE 22 PHARMACEUTICAL GELATIN MARKET FOR TABLETS, BY REGION, 2020–2027 (USD MILLION)
TABLE 23 NORTH AMERICA: PHARMACEUTICAL GELATIN MARKET FOR TABLETS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 24 EUROPE: PHARMACEUTICAL GELATIN MARKET FOR TABLETS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 25 ASIA PACIFIC: PHARMACEUTICAL GELATIN MARKET FOR TABLETS, BY COUNTRY, 2020–2027 (USD MILLION)
6.5 ABSORBABLE HEMOSTATS
6.5.1 INCREASED ADOPTION OF ABSORBABLE HEMOSTATS TO DRIVE MARKET
TABLE 26 PHARMACEUTICAL GELATIN MARKET FOR ABSORBABLE HEMOSTATS, BY REGION, 2020–2027 (USD MILLION)
TABLE 27 NORTH AMERICA: PHARMACEUTICAL GELATIN MARKET FOR ABSORBABLE HEMOSTATS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 28 EUROPE: PHARMACEUTICAL GELATIN MARKET FOR ABSORBABLE HEMOSTATS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 29 ASIA PACIFIC: PHARMACEUTICAL GELATIN MARKET FOR ABSORBABLE HEMOSTATS, BY COUNTRY, 2020–2027 (USD MILLION)
6.6 OTHER APPLICATIONS
TABLE 30 PHARMACEUTICAL GELATIN MARKET FOR OTHER APPLICATIONS, BY REGION, 2020–2027 (USD MILLION)
TABLE 31 NORTH AMERICA: PHARMACEUTICAL GELATIN MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 32 EUROPE: PHARMACEUTICAL GELATIN MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 33 ASIA PACIFIC: PHARMACEUTICAL GELATIN MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
7 PHARMACEUTICAL GELATIN MARKET, BY SOURCE (Page No. - 81)
7.1 INTRODUCTION
TABLE 34 AMINO ACID COMPOSITION OF GELATINS, BY SOURCE
TABLE 35 PHARMACEUTICAL GELATIN MARKET, BY SOURCE, 2020–2027 (USD MILLION)
TABLE 36 PHARMACEUTICAL GELATIN MARKET, BY SOURCE, 2020–2027 (KT)
7.2 PORCINE
7.2.1 LOWER MANUFACTURING COSTS OF PORCINE RAW MATERIALS TO PROPEL MARKET GROWTH
TABLE 37 US: PORK EXPORTS IN USD MILLION (2017-2021)
TABLE 38 PORCINE PHARMACEUTICAL GELATIN MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 39 NORTH AMERICA: PORCINE PHARMACEUTICAL GELATIN MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 40 EUROPE: PORCINE PHARMACEUTICAL GELATIN MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 41 ASIA PACIFIC: PORCINE PHARMACEUTICAL GELATIN MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.3 BOVINE SKIN
7.3.1 INCREASING AVAILABILITY OF BOVINE SKIN TO BOOST GROWTH
TABLE 42 BOVINE SKIN PHARMACEUTICAL GELATIN MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 43 NORTH AMERICA: BOVINE SKIN PHARMACEUTICAL GELATIN MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 44 EUROPE: BOVINE SKIN PHARMACEUTICAL GELATIN MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 45 ASIA PACIFIC: BOVINE SKIN PHARMACEUTICAL GELATIN MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.4 BOVINE BONE
7.4.1 ADVANTAGES OF BOVINE BONE LIKELY TO SUPPORT DEMAND GROWTH
TABLE 46 BOVINE BONE PHARMACEUTICAL GELATIN MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 47 NORTH AMERICA: BOVINE BONE PHARMACEUTICAL GELATIN MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 48 EUROPE: BOVINE BONE PHARMACEUTICAL GELATIN MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 49 ASIA PACIFIC: BOVINE BONE PHARMACEUTICAL GELATIN MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.5 MARINE
7.5.1 INCIDENCE OF ZOONOTIC DISEASES IN CATTLE AND PIGS TO DRIVE DEMAND FOR MARINE GELATIN
TABLE 50 MARINE PHARMACEUTICAL GELATIN MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 51 NORTH AMERICA: MARINE PHARMACEUTICAL GELATIN MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 52 EUROPE: MARINE PHARMACEUTICAL GELATIN MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 53 ASIA PACIFIC: MARINE PHARMACEUTICAL GELATIN MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.6 POULTRY
7.6.1 AVAILABILITY OF POULTRY AS A RAW MATERIAL TO BOOST UTILITY
TABLE 54 POULTRY PHARMACEUTICAL GELATIN MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 55 NORTH AMERICA: POULTRY PHARMACEUTICAL GELATIN MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 56 EUROPE: POULTRY PHARMACEUTICAL GELATIN MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 57 ASIA PACIFIC: POULTRY PHARMACEUTICAL GELATIN MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
8 PHARMACEUTICAL GELATIN MARKET, BY FUNCTION (Page No. - 94)
8.1 INTRODUCTION
TABLE 58 PHARMACEUTICAL GELATIN MARKET, BY FUNCTION, 2020–2027 (USD MILLION)
8.2 STABILIZING AGENTS
8.2.1 RISING VACCINE AND CAPSULE PRODUCTION TO DRIVE DEMAND FOR STABILIZING AGENTS
TABLE 59 PHARMACEUTICAL GELATIN MARKET FOR STABILIZING AGENTS, BY REGION, 2020–2027 (USD MILLION)
TABLE 60 NORTH AMERICA: PHARMACEUTICAL GELATIN MARKET FOR STABILIZING AGENTS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 61 EUROPE: PHARMACEUTICAL GELATIN MARKET FOR STABILIZING AGENTS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 62 ASIA PACIFIC: PHARMACEUTICAL GELATIN MARKET FOR STABILIZING AGENTS, BY COUNTRY, 2020–2027 (USD MILLION)
8.3 THICKENING AGENTS
8.3.1 GROWING USE OF GELATIN IN SYRUPS AND LIQUID DOSAGE FORMS TO DRIVE MARKET
TABLE 63 PHARMACEUTICAL GELATIN MARKET FOR THICKENING AGENTS, BY REGION, 2020–2027 (USD MILLION)
TABLE 64 NORTH AMERICA: PHARMACEUTICAL GELATIN MARKET FOR THICKENING AGENTS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 65 EUROPE: PHARMACEUTICAL GELATIN MARKET FOR THICKENING AGENTS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 66 ASIA PACIFIC: PHARMACEUTICAL GELATIN MARKET FOR THICKENING AGENTS, BY COUNTRY, 2020–2027 (USD MILLION)
8.4 GELLING AGENTS & OTHER FUNCTIONS
8.4.1 WIDE APPLICATIONS IN SOFTGEL CAPSULES AND HEMOSTATS TO BOOST DEMAND FOR GELLING AGENTS
TABLE 67 PHARMACEUTICAL GELATIN MARKET FOR GELLING AGENTS & OTHER FUNCTIONS, BY REGION, 2020–2027 (USD MILLION)
TABLE 68 NORTH AMERICA: PHARMACEUTICAL GELATIN MARKET FOR GELLING AGENTS & OTHER FUNCTIONS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 69 EUROPE: PHARMACEUTICAL GELATIN MARKET FOR GELLING AGENTS & OTHER FUNCTIONS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 70 ASIA PACIFIC: PHARMACEUTICAL GELATIN MARKET FOR GELLING AGENTS & OTHER FUNCTIONS, BY COUNTRY, 2020–2027 (USD MILLION)
9 PHARMACEUTICAL GELATIN MARKET, BY TYPE (Page No. - 102)
9.1 INTRODUCTION
TABLE 71 PHARMACEUTICAL GELATIN MARKET, BY TYPE, 2020–2027 (USD MILLION)
9.2 TYPE B GELATIN
9.2.1 INCREASED DEMAND FOR BOVINE-BASED GELATIN TO PROPEL MARKET GROWTH
TABLE 72 NUTRITIONAL COMPOSITION OF TYPE B GELATIN
TABLE 73 TYPE B PHARMACEUTICAL GELATIN MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 74 NORTH AMERICA: TYPE B PHARMACEUTICAL GELATIN MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 75 EUROPE: TYPE B PHARMACEUTICAL GELATIN MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 76 ASIA PACIFIC: TYPE B PHARMACEUTICAL GELATIN MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
9.3 TYPE A GELATIN
9.3.1 COST-EFFECTIVENESS OF PROCESSING TYPE A GELATIN TO DRIVE GROWTH
TABLE 77 NUTRITIONAL COMPOSITION OF TYPE A GELATIN
TABLE 78 TYPE A PHARMACEUTICAL GELATIN MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 79 NORTH AMERICA: TYPE A PHARMACEUTICAL GELATIN MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 80 EUROPE: TYPE A PHARMACEUTICAL GELATIN MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 81 ASIA PACIFIC: TYPE A PHARMACEUTICAL GELATIN MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
10 PHARMACEUTICAL GELATIN MARKET, BY REGION (Page No. - 108)
10.1 INTRODUCTION
TABLE 82 PHARMACEUTICAL GELATIN MARKET, BY REGION, 2020–2027 (USD MILLION)
10.2 NORTH AMERICA
FIGURE 21 NORTH AMERICA: PHARMACEUTICAL GELATIN MARKET SNAPSHOT
TABLE 83 NORTH AMERICA: PHARMACEUTICAL GELATIN MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 84 NORTH AMERICA: PHARMACEUTICAL GELATIN MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 85 NORTH AMERICA: PHARMACEUTICAL GELATIN MARKET, BY SOURCE, 2020–2027 (USD MILLION)
TABLE 86 NORTH AMERICA: PHARMACEUTICAL GELATIN MARKET, BY FUNCTION, 2020–2027 (USD MILLION)
TABLE 87 NORTH AMERICA: PHARMACEUTICAL GELATIN MARKET, BY TYPE, 2020–2027 (USD MILLION)
10.2.1 US
10.2.1.1 Increased prevalence of chronic diseases to drive market
TABLE 88 US: PHARMACEUTICAL GELATIN MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 89 US: PHARMACEUTICAL GELATIN MARKET, BY SOURCE, 2020–2027 (USD MILLION)
TABLE 90 US: PHARMACEUTICAL GELATIN MARKET, BY FUNCTION, 2020–2027 (USD MILLION)
TABLE 91 US: PHARMACEUTICAL GELATIN MARKET, BY TYPE, 2020–2027 (USD MILLION)
10.2.2 CANADA
10.2.2.1 Increasing demand for biopharmaceuticals to support growth
TABLE 92 CANADA: PHARMACEUTICAL GELATIN MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 93 CANADA: PHARMACEUTICAL GELATIN MARKET, BY SOURCE, 2020–2027 (USD MILLION)
TABLE 94 CANADA: PHARMACEUTICAL GELATIN MARKET, BY FUNCTION, 2020–2027 (USD MILLION)
TABLE 95 CANADA: PHARMACEUTICAL GELATIN MARKET, BY TYPE, 2020–2027 (USD MILLION)
10.3 EUROPE
TABLE 96 EUROPE: PHARMACEUTICAL GELATIN MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 97 EUROPE: PHARMACEUTICAL GELATIN MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 98 EUROPE: PHARMACEUTICAL GELATIN MARKET, BY SOURCE, 2020–2027 (USD MILLION)
TABLE 99 EUROPE: PHARMACEUTICAL GELATIN MARKET, BY FUNCTION, 2020–2027 (USD MILLION)
TABLE 100 EUROPE: PHARMACEUTICAL GELATIN MARKET, BY TYPE, 2020–2027 (USD MILLION)
10.3.1 GERMANY
10.3.1.1 Rising focus and investment in pharmaceutical R&D to promote market growth
TABLE 101 GERMANY: PHARMACEUTICAL GELATIN MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 102 GERMANY: PHARMACEUTICAL GELATIN MARKET, BY SOURCE, 2020–2027 (USD MILLION)
TABLE 103 GERMANY: PHARMACEUTICAL GELATIN MARKET, BY FUNCTION, 2020–2027 (USD MILLION)
TABLE 104 GERMANY: PHARMACEUTICAL GELATIN MARKET, BY TYPE, 2020–2027 (USD MILLION)
10.3.2 UK
10.3.2.1 Investments in novel drug development to propel demand for pharmaceutical gelatin
TABLE 105 UK: PHARMACEUTICAL GELATIN MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 106 UK: PHARMACEUTICAL GELATIN MARKET, BY SOURCE, 2020–2027 (USD MILLION)
TABLE 107 UK: PHARMACEUTICAL GELATIN MARKET, BY FUNCTION, 2020–2027 (USD MILLION)
TABLE 108 UK: PHARMACEUTICAL GELATIN MARKET, BY TYPE, 2020–2027 (USD MILLION)
10.3.3 FRANCE
10.3.3.1 Increased investment in pharmaceutical R&D to drive demand for pharmaceutical gelatin
TABLE 109 FRANCE: PHARMACEUTICAL GELATIN MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 110 FRANCE: PHARMACEUTICAL GELATIN MARKET, BY SOURCE, 2020–2027 (USD MILLION)
TABLE 111 FRANCE: PHARMACEUTICAL GELATIN MARKET, BY FUNCTION, 2020–2027 (USD MILLION)
TABLE 112 FRANCE: PHARMACEUTICAL GELATIN MARKET, BY TYPE, 2020–2027 (USD MILLION)
10.3.4 ITALY
10.3.4.1 Pharma R&D and innovation efforts to boost gelatin usage
TABLE 113 ITALY: PHARMACEUTICAL GELATIN MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 114 ITALY: PHARMACEUTICAL GELATIN MARKET, BY SOURCE, 2020–2027 (USD MILLION)
TABLE 115 ITALY: PHARMACEUTICAL GELATIN MARKET, BY FUNCTION, 2020–2027 (USD MILLION)
TABLE 116 ITALY: PHARMACEUTICAL GELATIN MARKET, BY TYPE, 2020–2027 (USD MILLION)
10.3.5 SPAIN
10.3.5.1 Growing pharma manufacturing to fuel demand for gelatin
TABLE 117 SPAIN: PHARMACEUTICAL GELATIN MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 118 SPAIN: PHARMACEUTICAL GELATIN MARKET, BY SOURCE, 2020–2027 (USD MILLION)
TABLE 119 SPAIN: PHARMACEUTICAL GELATIN MARKET, BY FUNCTION, 2020–2027 (USD MILLION)
TABLE 120 SPAIN: PHARMACEUTICAL GELATIN MARKET, BY TYPE, 2020–2027 (USD MILLION)
10.3.6 REST OF EUROPE
TABLE 121 ROE: PHARMACEUTICAL GELATIN MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 122 ROE: PHARMACEUTICAL GELATIN MARKET, BY SOURCE, 2020–2027 (USD MILLION)
TABLE 123 ROE: PHARMACEUTICAL GELATIN MARKET, BY FUNCTION, 2020–2027 (USD MILLION)
TABLE 124 ROE: PHARMACEUTICAL GELATIN MARKET, BY TYPE, 2020–2027 (USD MILLION)
10.4 ASIA PACIFIC
FIGURE 22 ASIA PACIFIC: PHARMACEUTICAL GELATIN MARKET SNAPSHOT
TABLE 125 ASIA PACIFIC: PHARMACEUTICAL GELATIN MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 126 ASIA PACIFIC: PHARMACEUTICAL GELATIN MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 127 ASIA PACIFIC: PHARMACEUTICAL GELATIN MARKET, BY SOURCE, 2020–2027 (USD MILLION)
TABLE 128 ASIA PACIFIC: PHARMACEUTICAL GELATIN MARKET, BY FUNCTION, 2020–2027 (USD MILLION)
TABLE 129 ASIA PACIFIC: PHARMACEUTICAL GELATIN MARKET, BY TYPE, 2020–2027 (USD MILLION)
10.4.1 JAPAN
10.4.1.1 Increasing aging population to create growth opportunities
TABLE 130 JAPAN: PHARMACEUTICAL GELATIN MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 131 JAPAN: PHARMACEUTICAL GELATIN MARKET, BY SOURCE, 2020–2027 (USD MILLION)
TABLE 132 JAPAN: PHARMACEUTICAL GELATIN MARKET, BY FUNCTION, 2020–2027 (USD MILLION)
TABLE 133 JAPAN: PHARMACEUTICAL GELATIN MARKET, BY TYPE, 2020–2027 (USD MILLION)
10.4.2 CHINA
10.4.2.1 Large population and availability of raw materials to contribute to market growth in China
TABLE 134 CHINA: PHARMACEUTICAL GELATIN MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 135 CHINA: PHARMACEUTICAL GELATIN MARKET, BY SOURCE, 2020–2027 (USD MILLION)
TABLE 136 CHINA: PHARMACEUTICAL GELATIN MARKET, BY FUNCTION, 2020–2027 (USD MILLION)
TABLE 137 CHINA: PHARMACEUTICAL GELATIN MARKET, BY TYPE, 2020–2027 (USD MILLION)
10.4.3 INDIA
10.4.3.1 Booming pharmaceutical industry to drive market
TABLE 138 INDIA: PHARMACEUTICAL GELATIN MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 139 INDIA: PHARMACEUTICAL GELATIN MARKET, BY SOURCE, 2020–2027 (USD MILLION)
TABLE 140 INDIA: PHARMACEUTICAL GELATIN MARKET, BY FUNCTION, 2020–2027 (USD MILLION)
TABLE 141 INDIA: PHARMACEUTICAL GELATIN MARKET, BY TYPE, 2020–2027 (USD MILLION)
10.4.4 REST OF ASIA PACIFIC
TABLE 142 ROAPAC: PHARMACEUTICAL GELATIN MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 143 ROAPAC: PHARMACEUTICAL GELATIN MARKET, BY SOURCE, 2020–2027 (USD MILLION)
TABLE 144 ROAPAC: PHARMACEUTICAL GELATIN MARKET, BY FUNCTION, 2020–2027 (USD MILLION)
TABLE 145 ROAPAC: PHARMACEUTICAL GELATIN MARKET, BY TYPE, 2020–2027 (USD MILLION)
10.5 LATIN AMERICA
10.5.1 RISING DEMAND FOR PHARMA GELATIN IN LATIN AMERICA TO DRIVE MARKET GROWTH
TABLE 146 LATAM: PHARMACEUTICAL GELATIN MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 147 LATAM: PHARMACEUTICAL GELATIN MARKET, BY SOURCE, 2020–2027 (USD MILLION)
TABLE 148 LATAM: PHARMACEUTICAL GELATIN MARKET, BY FUNCTION, 2020–2027 (USD MILLION)
TABLE 149 LATAM: PHARMACEUTICAL GELATIN MARKET, BY TYPE, 2020–2027 (USD MILLION)
10.6 MIDDLE EAST & AFRICA
10.6.1 RISING ADOPTION OF GELATIN-BASED PHARMA PRODUCTS TO PROPEL GROWTH
TABLE 150 MEA: PHARMACEUTICAL GELATIN MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 151 MEA: PHARMACEUTICAL GELATIN MARKET, BY SOURCE, 2020–2027 (USD MILLION)
TABLE 152 MEA: PHARMACEUTICAL GELATIN MARKET, BY FUNCTION, 2020–2027 (USD MILLION)
TABLE 153 MEA: PHARMACEUTICAL GELATIN MARKET, BY TYPE, 2020–2027 (USD MILLION)
11 COMPETITIVE LANDSCAPE (Page No. - 144)
11.1 INTRODUCTION
11.2 RIGHT-TO-WIN APPROACHES ADOPTED BY KEY PLAYERS
FIGURE 23 PHARMACEUTICAL GELATIN MARKET: STRATEGIES ADOPTED
11.3 REVENUE ANALYSIS
FIGURE 24 REVENUE ANALYSIS FOR KEY COMPANIES (2019–2021)
11.4 MARKET SHARE ANALYSIS
FIGURE 25 PHARMACEUTICAL GELATIN MARKET SHARE ANALYSIS, BY KEY PLAYER, 2021
TABLE 154 PHARMACEUTICAL GELATIN MARKET: DEGREE OF COMPETITION
11.5 COMPANY EVALUATION QUADRANT
11.5.1 STARS
11.5.2 EMERGING LEADERS
11.5.3 PERVASIVE PLAYERS
11.5.4 PARTICIPANTS
FIGURE 26 PHARMACEUTICAL GELATIN MARKET: COMPANY EVALUATION QUADRANT, 2021
11.6 COMPANY EVALUATION QUADRANT FOR SMES/START-UPS (2021)
11.6.1 PROGRESSIVE COMPANIES
11.6.2 STARTING BLOCKS
11.6.3 RESPONSIVE COMPANIES
11.6.4 DYNAMIC COMPANIES
FIGURE 27 PHARMACEUTICAL GELATIN MARKET: COMPANY EVALUATION QUADRANT FOR SMES/START-UPS, 2021
11.7 COMPETITIVE BENCHMARKING
TABLE 155 OVERALL COMPANY FOOTPRINT
TABLE 156 COMPANY PRODUCT FOOTPRINT
TABLE 157 COMPANY REGIONAL FOOTPRINT
11.8 COMPETITIVE SCENARIO AND TRENDS
TABLE 158 PHARMACEUTICAL GELATIN MARKET: PRODUCT LAUNCHES, JANUARY 2019–OCTOBER 2022
TABLE 159 PHARMACEUTICAL GELATIN MARKET: DEALS, JANUARY 2019–OCTOBER 2022
TABLE 160 PHARMACEUTICAL GELATIN MARKET: OTHER DEVELOPMENTS, JANUARY 2019–OCTOBER 2022
12 COMPANY PROFILES (Page No. - 156)
12.1 KEY PLAYERS
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.1 DARLING INGREDIENTS
TABLE 161 DARLING INGREDIENTS: BUSINESS OVERVIEW
FIGURE 28 DARLING INGREDIENTS: COMPANY SNAPSHOT (2022)
12.1.2 NITTA GELATIN
TABLE 162 NITTA GELATIN: BUSINESS OVERVIEW
FIGURE 29 NITTA GELATIN: COMPANY SNAPSHOT (2022)
12.1.3 TESSENDERLO GROUP
TABLE 163 TESSENDERLO GROUP: BUSINESS OVERVIEW
FIGURE 30 TESSENDERLO GROUP: COMPANY SNAPSHOT (2022)
12.1.4 GELITA AG
TABLE 164 GELITA AG: BUSINESS OVERVIEW
12.1.5 WEISHARDT
TABLE 165 WEISHARDT: BUSINESS OVERVIEW
12.1.6 TROBAS GELATINE
TABLE 166 TROBAS GELATINE: BUSINESS OVERVIEW
12.1.7 LAPI GELATINE
TABLE 167 LAPI GELATINE S.P.A: BUSINESS OVERVIEW
12.1.8 INDIA GELATINE & CHEMICALS
TABLE 168 INDIA GELATINE & CHEMICALS: BUSINESS OVERVIEW
FIGURE 31 INDIA GELATINE & CHEMICALS: COMPANY SNAPSHOT (2022)
12.1.9 GELNEX
TABLE 169 GELNEX: BUSINESS OVERVIEW
12.1.10 JUNCA GELATINES
TABLE 170 JUNCA GELATINES: BUSINESS OVERVIEW
12.1.11 HEBEI CHENGDA MINGJIAO
TABLE 171 HEBEI CHENGDA MINGJIAO: BUSINESS OVERVIEW
12.1.12 ITALGEL
TABLE 172 ITALGEL: BUSINESS OVERVIEW
12.1.13 XIAMEN GELKEN GELATIN
TABLE 173 XIAMEN GELKEN GELATIN BUSINESS OVERVIEW
12.1.14 GELCO INTERNATIONAL
TABLE 174 GELCO INTERNATIONAL: BUSINESS OVERVIEW
12.1.15 HENAN BOOM GELATIN
TABLE 175 HENAN BOOM GELATIN: BUSINESS OVERVIEW
12.1.16 NORLAND PRODUCTS
TABLE 176 NORLAND PRODUCTS: BUSINESS OVERVIEW
12.1.17 GELIKO
TABLE 177 GELIKO: BUSINESS OVERVIEW
12.1.18 KENNEY & ROSS LIMITED
TABLE 178 KENNEY & ROSS LIMITED: BUSINESS OVERVIEW
12.1.19 BAOTOU DONGBAO BIO-TECH
TABLE 179 BAOTOU DONGBAO BIO-TECH: BUSINESS OVERVIEW
12.1.20 GELTEC
TABLE 180 GELTEC: BUSINESS OVERVIEW
12.1.21 NARMADA GELATINES.
TABLE 181 NARMADA GELATINES: BUSINESS OVERVIEW
FIGURE 32 NARMADA GELATINES: COMPANY SNAPSHOT (2022)
12.1.22 REINERT GRUPPE INGREDIENTS GMBH
TABLE 182 REINERT GRUPPE INGREDIENTS GMBH: BUSINESS OVERVIEW
12.1.23 JELLICE GELATIN & COLLAGEN
TABLE 183 JELLICE GELATIN AND COLLAGEN: BUSINESS OVERVIEW
12.1.24 STERLING GELATIN
TABLE 184 STERLING GELATIN: BUSINESS OVERVIEW
12.1.25 ATHOS COLLAGEN
TABLE 185 ATHOS COLLAGEN: BUSINESS OVERVIEW
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13 APPENDIX (Page No. - 190)
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 CUSTOMIZATION OPTIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS
This study involved four major activities in estimating the current size of the pharmaceutical gelatin market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate the market size of segments.
Secondary Research
Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the pharmaceutical gelatin market. The secondary sources used for this study include Gelatin Manufacturer’s Institute of America (GMIA), Gelatin Manufacturers Association of Asia Pacific (GMAP), Gelatin Manufacturers Association of Europe (GME), European Federation of Pharmaceutical Industries and Associations (EFPIA), Pharmaceutical Research and Manufacturers of America (PhRMA), US Food and Drug Administration (USFDA), European Food Safety Authority (EFSA), United States Department of Agriculture (USDA), and Organisation for Economic Co-operation and Development (OECD), and corporate filings such as annual reports, SEC filings, investor presentations, and financial statements; press releases; and trade, business, professional associations and among others. These sources were also used to obtain key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.
Primary Research
In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify the critical qualitative and quantitative information as well as assess future prospects of the market. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of the primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the pharmaceutical gelatin market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
- The key players in the industry and market have been identified through extensive secondary research
- The revenues generated from the pharmaceutical gelatin business of leading players have been determined through primary and secondary research
- All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources
Data Triangulation
After arriving at the overall market size from the market size estimation process, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Report Objectives
- To define, describe, and forecast the global pharmaceutical gelatin market based on the application, source, function, type and region
- To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, restraints, and opportunities)
- To strategically analyze micromarkets with respect to individual growth trends, future prospects, and contributions to the overall pharmaceutical gelatin market
- To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of the market segments with respect to five main regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa
- To strategically profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
- To track and analyze competitive developments such as acquisitions, product launches, expansions, and R&D activities in the pharmaceutical gelatin market.
Available Customizations
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for this report:
Company Information
- Detailed analysis and profiling of additional market players (up to five)
Volume
- Volume by region can be provided by function, application and type
Generating Response ...
Growth opportunities and latent adjacency in Pharmaceutical Gelatin Market